
Sign up to save your podcasts
Or
In this episode we dive into Medipharm Lab's Q1 2020 results which greatly disappointed the market
- What's going on with LABS? Why did it have such a drop off in revenue?
- How does it compare to Valens?
- Examining their recent $37M financing (good and bad)
- How the slow 2.0 rollout is hurting the extraction industry
- Why 2019 was such a good year for LABS - will it recover?
- How will the extraction landscape look in the next 1-3 years?
4.6
6767 ratings
In this episode we dive into Medipharm Lab's Q1 2020 results which greatly disappointed the market
- What's going on with LABS? Why did it have such a drop off in revenue?
- How does it compare to Valens?
- Examining their recent $37M financing (good and bad)
- How the slow 2.0 rollout is hurting the extraction industry
- Why 2019 was such a good year for LABS - will it recover?
- How will the extraction landscape look in the next 1-3 years?
3,381 Listeners
3,076 Listeners
931 Listeners
95 Listeners
196 Listeners
81 Listeners
9,832 Listeners
466 Listeners
107 Listeners
250 Listeners
350 Listeners
7 Listeners
6 Listeners
13 Listeners
131 Listeners